US Patent Issued to AELIS FARMA, UNIVERSITE DE BORDEAUX on March 24 for "3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders" (French, Spanish Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,884, issued on March 24, was assigned to AELIS FARMA (Bordeaux, France) and UNIVERSITE DE BORDEAUX (Bordeaux, France).

"3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders" was invented by Pier Vincenzo Piazza (Bordeaux, France), Sandy Fabre (Bordeaux, France), Stephanie Monlezun (Bordeaux, France), Mathilde Metna (Bordeaux, France), Monique Vallee (Bordeaux, France), Jean-Michel Revest (Bordeaux, France), Daniela Cota (Bordeaux, France), Giovanni Marsicano (Bordeaux, France), Aline Marighetto (Bordeaux, France), Andres Ozaita (Barcelona, Spain) and Rafael Maldonado (Barcelona, Spain).

According to the abstract* released by the U.S....